SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Q1 Interim Management Statement

6 Feb 2020 07:00

RNS Number : 1261C
Victrex PLC
06 February 2020
 
 

 

 

6 February 2020

Victrex plc - AGM and Q1 Interim Management Statement

'Solid start to FY 2020 against weaker comparatives; expectations unchanged'

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting (AGM) being held today. Q1 covers the period 1 October to 31 December 2019.

Against much weaker comparatives, the Group saw an initial improvement during Q1. Automotive delivered good year on year and sequential growth, partly reflecting phasing, whilst Electronics and Value Added Resellers continued to see some signs of stability. Aerospace growth continued, although we are mindful of some headwinds within the industry this year, whilst Energy was notably weaker. In Medical, we saw a stable performance, with good growth continuing in Asia.

For Q1 as a whole, revenue of £67.7m was up 6% on the prior year (Q1 2019: £64.1m), with Q1 Group sales volume of 877 tonnes being up 7% on the prior year (Q1 2019: 822 tonnes). On a year to date basis, the Group remains ahead of last year, with performance in January being broadly in line with the strong January of the prior year.

Mega-programmes

Our pipeline of 'mega-programmes' remains strong. In Aerospace, we acquired the remaining equity in the TxV Aero Composites business from Tri-Mack. Our US facility in Rhode Island continues to manufacture a range of composite products, delivering commercial and prototype revenue. In Magma, Victrex is currently supporting the qualification pipe project for TechnipFMC's new Hybrid Flexible pipe targeted at opportunities in Brazil. Several smaller projects are also expected to deliver revenue this year, including in the Gulf of Mexico, North Sea and West Africa. In our PEEK Knee programme, we are moving closer to securing a second partner, as well as progressing discussions with major OEMs in this market.

 

Joint-venture investment in China

 

As previously communicated, Victrex completed a class 2 transaction on 13th January 2020, to create a joint-venture in China which will, subject to certain performance conditions, build and operate a 1,500 tonne PEEK manufacturing plant to serve that market. Commissioning of the facility is anticipated in early 2022, with Victrex's share of the overall investment expected to total £32m.

 

Financial position

Victrex retains a highly cash generative business model, with no material change to its financial position since 30 September 2019. Currency remains a modest tailwind for FY 2020, although we note that Sterling's rerating over recent months now implies a growing headwind for FY 2021.

Outlook

Jakob Sigurdsson, Chief Executive of Victrex, said: "This is a solid start to FY 2020, although it is against weaker comparatives in the prior year.

"Whilst it is pleasing to see some year on year progress in Automotive, partly reflecting phasing, and continuing signs of stability in Electronics and Value Added Resellers, we note the weaker performance in Energy, in line with recent industry commentary. Overall, our expectations are unchanged and at this early stage, we continue to be focused on making year-on-year progress. For the medium to long-term, our Polymer & Parts strategy keeps us well placed to deliver our growth opportunities."

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 7809 595831

Richard Armitage, Group Finance Director +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 08.30am GMT. Dial in details +44 (0) 3333 000804 PIN: 94528843#

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTTAMLTMTMMBAM
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.